Pamol 500 mg paracetamol

Pamol is a well-known over-the-counter analgesic and antipyretic medication used primarily for the relief of mild to moderate pain and fever. The brand has a significant presence in Northern European markets, particularly in Sweden and Denmark. Historically, the brand was part of the consumer healthcare portfolio of Takeda Pharmaceuticals, a major Japanese pharmaceutical company.

In a strategic shift to focus on core therapeutic areas, Takeda divested its non-core consumer healthcare assets in Europe to the Danish pharmaceutical company Orifarm Group in 2020. This transaction included the transfer of rights for Pamol along with other established brands and two manufacturing sites. Since the completion of this deal, Orifarm has been the ultimate owner of the brand. Manufacturing for the European market, including the Swedish version shown, is primarily handled at Orifarm's facilities in Poland. This arrangement ensures the continued availability of the trusted paracetamol brand under European oversight and distribution.